Lupus in Minority Populations
Systemic Lupus Erythematosus, a multi-organ system autoimmune disease, has been shown to affect ethnic minorities more frequently and more severely than other populations. Minorities are 3-4 times more likely to develop SLE and twice as likely to experience severe manifestation such as kidney disease. Finding personalized approaches to treating minority patients starts with quality research. In our talk with Dr. Ashira Blazer, an academic rheumatologist at NYU Langone Hospital, we will explore the presumed causes and contributors to disparities in SLE, future directions in management, and tools to help even the most vulnerable patients live well.
Dr. Ashira Blazer, Instructor, Division of Rheumatology, Department of Medicine, NYU Langone Health and NYU School of Medicine, New York
September 25, 2019
There are multiple chapters near you. Select your preferred chapter.
Serving the District of Columbia, Maryland, and Northern Virginia.
Serving southern Illinois up to and including Springfield, eastern Kansas, and Missouri
Serving northern and central Illinois
Serving north, central and west Texas, including Dallas/Fort Worth, San Antonio, Austin, El Paso, Lubbock, and surrounding areas
Serving all northern counties in New Jersey, south through Mercer and Ocean counties
Supporting lupus patients and advocates in New York and Connecticut.
Serving Philadelphia and southeastern Pennsylvania, all southern counties in New Jersey up through Burlington county, and Delaware
Serving Houston, Beaumont, Corpus Christi, Harlingen and surrounding areas in Texas
There are multiple walks near you.